Roivant Sciences Ltd. Common Shares vs VanEck Semiconductor ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while VanEck Semiconductor ETF trades at $603.71 (market cap $73.92B). The key difference: VanEck Semiconductor ETF is far larger — about 3× Roivant Sciences Ltd. Common Shares's market cap, and VanEck Semiconductor ETF is more actively traded (11,050,892 versus 6,279,442). Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and VanEck Semiconductor ETF for 101 Days on average.
| ROIV | SMH | |
|---|---|---|
Market Cap | $24.72B | $73.92B |
Volume | 6,279,442 | 11,050,892 |
Sector | Health | — |
52-Week High | $41.81 | $668.91 |
52-Week Low | $16.04 | $325.10 |
Typical Hold Time | 1 Days | 101 Days |
Enterprise Value | $20.99B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SMH trades at $603.33, down 3.47% on the day, but maintains a bullish technical outlook with strong moving average support. The semiconductor ETF has delivered exceptional returns, up approximately 69% year-to-date through September 30, 2026, significantly outperforming the broader market. Recent sector strength is driven by AI demand and positive industry developments, including AMD's $8.2 billion acquisition of World Labs.
The semiconductor sector's structural growth, particularly in AI applications, supports continued upside potential. However, concentration risk in top holdings like Nvidia and sensitivity to US-China trade tensions present meaningful headwinds. Current technical levels suggest support at $597 with resistance at $620, providing clear near-term trading parameters.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →